440 related articles for article (PubMed ID: 20149605)
1. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.
Wen YA; Liu D; Zhou QY; Huang SF; Luo P; Xiang Y; Sun S; Luo D; Dong YF; Zhang LP
Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605
[TBL] [Abstract][Full Text] [Related]
2. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse.
Canbay A; Feldstein A; Baskin-Bey E; Bronk SF; Gores GJ
J Pharmacol Exp Ther; 2004 Mar; 308(3):1191-6. PubMed ID: 14617689
[TBL] [Abstract][Full Text] [Related]
3. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.
Isayama F; Hines IN; Kremer M; Milton RJ; Byrd CL; Perry AW; McKim SE; Parsons C; Rippe RA; Wheeler MD
Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1318-28. PubMed ID: 16439470
[TBL] [Abstract][Full Text] [Related]
4. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases.
Li Z; Mizuno S; Nakamura T
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G639-46. PubMed ID: 17068118
[TBL] [Abstract][Full Text] [Related]
5. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
6. Biliary intervention augments chemotactic reaction and aggravates cholestatic liver injury in rats.
Chuang JH; Chang NK; Huang CC; Lo SK; Wang HC; Chen CM; Wu CL; Chou MH; Lin TK
J Surg Res; 2004 Aug; 120(2):210-8. PubMed ID: 15234215
[TBL] [Abstract][Full Text] [Related]
7. CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury.
Tamaki N; Hatano E; Taura K; Tada M; Kodama Y; Nitta T; Iwaisako K; Seo S; Nakajima A; Ikai I; Uemoto S
Am J Physiol Gastrointest Liver Physiol; 2008 Feb; 294(2):G498-505. PubMed ID: 18174271
[TBL] [Abstract][Full Text] [Related]
8. Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity.
Higuchi H; Bronk SF; Taniai M; Canbay A; Gores GJ
J Pharmacol Exp Ther; 2002 Nov; 303(2):461-7. PubMed ID: 12388624
[TBL] [Abstract][Full Text] [Related]
9. Alpha-1 antitrypsin Z protein (PiZ) increases hepatic fibrosis in a murine model of cholestasis.
Mencin A; Seki E; Osawa Y; Kodama Y; De Minicis S; Knowles M; Brenner DA
Hepatology; 2007 Nov; 46(5):1443-52. PubMed ID: 17668872
[TBL] [Abstract][Full Text] [Related]
10. Kupffer cells abrogate cholestatic liver injury in mice.
Gehring S; Dickson EM; San Martin ME; van Rooijen N; Papa EF; Harty MW; Tracy TF; Gregory SH
Gastroenterology; 2006 Mar; 130(3):810-22. PubMed ID: 16530521
[TBL] [Abstract][Full Text] [Related]
11. Proteasome inhibition attenuates hepatic injury in the bile duct-ligated mouse.
Anan A; Baskin-Bey ES; Isomoto H; Mott JL; Bronk SF; Albrecht JH; Gores GJ
Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G709-16. PubMed ID: 16798723
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling in whole liver of bile duct ligated rats: VEGF-A expression is up-regulated in hepatocytes adjacent to the portal tracts.
Tanaka A; Tsuneyama K; Mikami M; Uegaki S; Aiso M; Takikawa H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1993-2000. PubMed ID: 17914982
[TBL] [Abstract][Full Text] [Related]
13. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
[TBL] [Abstract][Full Text] [Related]
14. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
[TBL] [Abstract][Full Text] [Related]
15. Bombesin and neurotensin exert antiproliferative effects on oval cells and augment the regenerative response of the cholestatic rat liver.
Assimakopoulos SF; Tsamandas AC; Georgiou CD; Vagianos CE; Scopa CD
Peptides; 2010 Dec; 31(12):2294-303. PubMed ID: 20833216
[TBL] [Abstract][Full Text] [Related]
16. Involvement of STAT3-regulated hepatic soluble factors in attenuation of stellate cell activity and liver fibrogenesis in mice.
Shigekawa M; Takehara T; Kodama T; Hikita H; Shimizu S; Li W; Miyagi T; Hosui A; Tatsumi T; Ishida H; Kanto T; Hiramatsu N; Hayashi N
Biochem Biophys Res Commun; 2011 Mar; 406(4):614-20. PubMed ID: 21356197
[TBL] [Abstract][Full Text] [Related]
17. Characterization of time-related changes after experimental bile duct ligation.
Georgiev P; Jochum W; Heinrich S; Jang JH; Nocito A; Dahm F; Clavien PA
Br J Surg; 2008 May; 95(5):646-56. PubMed ID: 18196571
[TBL] [Abstract][Full Text] [Related]
18. Sortilin Deficiency Reduces Ductular Reaction, Hepatocyte Apoptosis, and Liver Fibrosis in Cholestatic-Induced Liver Injury.
Hubel E; Saroha A; Park WJ; Pewzner-Jung Y; Lavoie EG; Futerman AH; Bruck R; Fishman S; Dranoff JA; Shibolet O; Zvibel I
Am J Pathol; 2017 Jan; 187(1):122-133. PubMed ID: 27842214
[TBL] [Abstract][Full Text] [Related]
19. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat.
Tuchweber B; Desmoulière A; Bochaton-Piallat ML; Rubbia-Brandt L; Gabbiani G
Lab Invest; 1996 Jan; 74(1):265-78. PubMed ID: 8569191
[TBL] [Abstract][Full Text] [Related]
20. The Role of Phospho-c-Jun N-Terminal Kinase Expression on hepatocyte Necrosis and Autophagy in the Cholestatic Liver.
Kwak BJ; Choi HJ; Kim OH; Kim KH; You YK; Lee TY; Ahn J; Kim SJ
J Surg Res; 2019 Sep; 241():254-263. PubMed ID: 31035140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
